CA2344561A1 - Facteur de croissance c derive des plaquettes, adn le codant et ses utilisations - Google Patents
Facteur de croissance c derive des plaquettes, adn le codant et ses utilisations Download PDFInfo
- Publication number
- CA2344561A1 CA2344561A1 CA002344561A CA2344561A CA2344561A1 CA 2344561 A1 CA2344561 A1 CA 2344561A1 CA 002344561 A CA002344561 A CA 002344561A CA 2344561 A CA2344561 A CA 2344561A CA 2344561 A1 CA2344561 A1 CA 2344561A1
- Authority
- CA
- Canada
- Prior art keywords
- pdgf
- polypeptide
- leu
- glu
- ser
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/49—Platelet-derived growth factor [PDGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Optics & Photonics (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Publié sans précis
Applications Claiming Priority (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10246198P | 1998-09-30 | 1998-09-30 | |
US60/102,461 | 1998-09-30 | ||
US10810998P | 1998-11-12 | 1998-11-12 | |
US60/108,109 | 1998-11-12 | ||
US11074998P | 1998-12-03 | 1998-12-03 | |
US60/110,749 | 1998-12-03 | ||
US11300298P | 1998-12-18 | 1998-12-18 | |
US60/113,002 | 1998-12-18 | ||
US13542699P | 1999-05-21 | 1999-05-21 | |
US60/135,426 | 1999-05-21 | ||
US14402299P | 1999-07-15 | 1999-07-15 | |
US60/144,022 | 1999-07-15 | ||
PCT/US1999/022668 WO2000018212A2 (fr) | 1998-09-30 | 1999-09-30 | Facteur de croissance c derive des plaquettes, adn le codant et ses utilisations |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2344561A1 true CA2344561A1 (fr) | 2000-04-06 |
Family
ID=27557649
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002344561A Abandoned CA2344561A1 (fr) | 1998-09-30 | 1999-09-30 | Facteur de croissance c derive des plaquettes, adn le codant et ses utilisations |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1123408A1 (fr) |
JP (1) | JP2002525086A (fr) |
CN (1) | CN1330664A (fr) |
CA (1) | CA2344561A1 (fr) |
WO (1) | WO2000018212A2 (fr) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1064382B1 (fr) | 1998-03-17 | 2008-08-20 | Genentech, Inc. | Polypeptides homologues aux vegf et bmp1 |
DK1137773T3 (da) * | 1998-12-07 | 2008-12-08 | Zymogenetics Inc | Væsktfaktorhomolog ZVEGF3 |
US6432673B1 (en) | 1998-12-07 | 2002-08-13 | Zymogenetics, Inc. | Growth factor homolog ZVEGF3 |
WO2000059940A2 (fr) * | 1999-04-06 | 2000-10-12 | Eli Lilly And Company | Gene et proteine lies au facteur de croissance d'origine plaquettaire |
US6893637B1 (en) | 1999-10-21 | 2005-05-17 | Zymogenetics, Inc. | Method of treating fibrosis |
US20040086507A1 (en) * | 2000-10-19 | 2004-05-06 | Kenya Shitara | Antibody inhibiting vplf activity |
JP2004527506A (ja) * | 2001-03-09 | 2004-09-09 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 平滑筋細胞増殖のモジュレーション |
WO2005040194A2 (fr) * | 2003-10-24 | 2005-05-06 | Ludwig Institute For Cancer Research | Methodes et compositions d'activation et d'inhibition de pdgf-c |
US20060024302A1 (en) | 2004-03-05 | 2006-02-02 | Ludwig Institute For Cancer Research | Chimeric anti-VEGF-D antibodies and humanized anti-VEGF-D antibodies and methods of using same |
WO2005092921A2 (fr) * | 2004-03-22 | 2005-10-06 | Eli Lilly And Company | Variants d'epissage du facteur de croissance placentaire, utilisations de ces derniers |
ATE502956T1 (de) | 2005-08-15 | 2011-04-15 | Vegenics Pty Ltd | Modifizierte vegf und pdgf mit verbesserten angiogenen eigenschaften |
US8114399B2 (en) | 2006-05-17 | 2012-02-14 | Ludwig Institute For Cancer Research | Targeting VEGF-B regulation of fatty acid transporters to modulate human diseases |
CN101392026B (zh) * | 2008-10-09 | 2011-11-09 | 黄岚 | 用于预防和治疗纤维化类疾病以及肝癌的多肽 |
CA2871528A1 (fr) | 2012-04-24 | 2013-10-31 | Thrombogenics N.V. | Anticorps anti-pdgf-c |
CN104693286A (zh) * | 2015-04-06 | 2015-06-10 | 苏州普罗达生物科技有限公司 | 关于血管内皮生长因子c拮抗多肽及其应用 |
CN104744565A (zh) * | 2015-04-06 | 2015-07-01 | 苏州普罗达生物科技有限公司 | 一种血管内皮生长因子c拮抗多肽及其应用 |
CN104693285A (zh) * | 2015-04-06 | 2015-06-10 | 苏州普罗达生物科技有限公司 | 血管内皮生长因子c拮抗多肽及其应用 |
CN105175546A (zh) * | 2015-05-27 | 2015-12-23 | 连祺周 | 人血管内皮生长因子与表皮生长因子样结构域7的融合蛋白 |
JP7437000B2 (ja) | 2016-07-01 | 2024-02-22 | パラクライン セラピューティクス アーベー | Pdgf-ccの阻害のための方法および組成物 |
-
1999
- 1999-09-30 JP JP2000571742A patent/JP2002525086A/ja active Pending
- 1999-09-30 CA CA002344561A patent/CA2344561A1/fr not_active Abandoned
- 1999-09-30 WO PCT/US1999/022668 patent/WO2000018212A2/fr not_active Application Discontinuation
- 1999-09-30 EP EP99952989A patent/EP1123408A1/fr not_active Withdrawn
- 1999-09-30 CN CN99811565A patent/CN1330664A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
CN1330664A (zh) | 2002-01-09 |
WO2000018212A8 (fr) | 2007-11-22 |
WO2000018212A9 (fr) | 2000-09-08 |
JP2002525086A (ja) | 2002-08-13 |
EP1123408A1 (fr) | 2001-08-16 |
WO2000018212A2 (fr) | 2000-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6706687B1 (en) | Platelet-derived growth factor D | |
EP2107109B1 (fr) | Facteur D recombinant de croissance de cellules vasculaires endotheliales | |
CA2344561A1 (fr) | Facteur de croissance c derive des plaquettes, adn le codant et ses utilisations | |
JP2003517275A (ja) | 哺乳動物vegfレセプター−2に結合し、これを活性化するオルフウイルスnz2由来の血管内皮細胞増殖因子様タンパク質 | |
US20070042413A1 (en) | Platelet-derived growth factor D, DNA coding therefor, and uses thereof | |
US20020164687A1 (en) | Platelet-derived growth factor C, DNA coding therefor, and uses thereof | |
US20030211994A1 (en) | Composition and method for modulating vasculogenesis or angiogenesis | |
US20070172423A1 (en) | Composition and method for modulating vasculogenesis for angiogenesis | |
AU6502999A (en) | Platelet-derived growth factor c, dna coding therefor, and uses thereof | |
US20030082670A1 (en) | Platelet-derived growth factor C, DNA coding therefor, and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |